These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 6239089

  • 1. Involuntary movement disorders.
    Still CN.
    Neurol Clin; 1984 Feb; 2(1):71-89. PubMed ID: 6239089
    [Abstract] [Full Text] [Related]

  • 2. Therapeutics of disordered movement.
    Sears ES.
    Am Fam Physician; 1977 Sep; 16(3):145-54. PubMed ID: 143204
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Neurologic indications for bromocriptine (in addition to Parkinson's disease)].
    Destee A.
    LARC Med; 1984 Feb; 4(2):107-11. PubMed ID: 6232436
    [No Abstract] [Full Text] [Related]

  • 5. [Therapeutic use of tiapride in movement disorders].
    Mathé JF, Cler JM, Venisse JL.
    Sem Hop; 1978 May; 54(13-16):517-20. PubMed ID: 211595
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Drug treatment of diseases characterized by abnormal movements.
    Marsden CD.
    Proc R Soc Med; 1973 Sep; 66(9):871-3. PubMed ID: 4281483
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Deanol in the management of involuntary movement disorders: a review.
    Casey DE.
    Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):7-15. PubMed ID: 145359
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Specific therapy of extrapyramidal-motor syndromes].
    Hartmann-von Monakow K.
    Bibl Psychiatr Neurol; 1969 Dec; 139():705-11. PubMed ID: 4257724
    [No Abstract] [Full Text] [Related]

  • 17. Movement disorders in the elderly.
    Gilmore R.
    Geriatrics; 1984 Jun; 39(6):65-8, 72-6. PubMed ID: 6144615
    [No Abstract] [Full Text] [Related]

  • 18. Movement disorders with neuroleptic drug treatment.
    Tarsy D.
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of dyskinetic syndromes].
    Werdelin LM, Pakkenberg H.
    Nord Med; 1994 Sep; 109(12):341-4. PubMed ID: 7997372
    [Abstract] [Full Text] [Related]

  • 20. Treatment of dyskinetic and dystonic disorders with CF 25-397: clinical and pharmacological aspects.
    Frattola L, Albizzati MG, Bassi S, Spano PF, Trabucchi M.
    Adv Biochem Psychopharmacol; 1980 Sep; 23():381-6. PubMed ID: 6446848
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.